Literature DB >> 12373543

Repeated topical application of growth hormone attenuates blood-spinal cord barrier permeability and edema formation following spinal cord injury: an experimental study in the rat using Evans blue, ([125])I-sodium and lanthanum tracers.

F Nyberg1, H S Sharma.   

Abstract

The neuroprotective efficacy of growth hormone on a focal spinal cord trauma induced alteration in the blood-spinal cord barrier (BSCB) and edema formation was examined in a rat model. Under Equithesin anaesthesia, one segment laminectomy was done over the T10-11 segments. Spinal cord injury was produced by making an incision into the right dorsal horn of the T10-11 segments (2 mm deep and 4 mm long). The animals were allowed to survive 5 h after injury. Highly purified rat growth hormone [rGH, 25 microl of a 1microg/ml solution) was applied over 10 sec topically on the exposed surface of the spinal cord 30 min before injury. The identical doses of the rGH were repeated 0 min, 30 min, 60 min, 120 min, 180 min and 240 min following injury. Saline (0.9% NaCl) treated traumatised rats at identical intervals served as controls. Traumatised rats treated with saline exhibited marked edema formation and extravasation of Evans blue and ([125])Iodine tracers in the spinal cord. At the ultrastructural level, perivascular edema and exudation of lanthanum across the endothelial cells was quite frequent in the spinal cord. Pretreatment with rGH significantly attenuated the edema formation and the extravasation of tracers in the spinal cord. In these rats, perivascular edema and infiltration of lanthanum across the endothelial cells was not much evident. These observations show that the rGH has the capacity to reduce the early manifestations of microvascular permeability disturbances and edema formation following trauma and further suggest a possible therapeutic potential of the hormone for the treatment of spinal cord injuries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12373543     DOI: 10.1007/s00726-001-0134-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  8 in total

1.  Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord.

Authors:  Dafin F Muresanu; Aruna Sharma; José V Lafuente; Ranjana Patnaik; Z Ryan Tian; Fred Nyberg; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2015-07-01       Impact factor: 5.590

Review 2.  Therapeutic targets and nanomaterial-based therapies for mitigation of secondary injury after spinal cord injury.

Authors:  Jun Gao; Minkyung Khang; Zhen Liao; Megan Detloff; Jeoung Soo Lee
Journal:  Nanomedicine (Lond)       Date:  2021-08-17       Impact factor: 6.096

Review 3.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

4.  NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.

Authors:  Anna Victoria Leonard; Emma Thornton; Robert Vink
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

5.  Regulatory effects of intermittent noxious stimulation on spinal cord injury-sensitive microRNAs and their presumptive targets following spinal cord contusion.

Authors:  Eric R Strickland; Sarah A Woller; Sandra M Garraway; Michelle A Hook; James W Grau; Rajesh C Miranda
Journal:  Front Neural Circuits       Date:  2014-09-18       Impact factor: 3.492

6.  miR-320a affects spinal cord edema through negatively regulating aquaporin-1 of blood-spinal cord barrier during bimodal stage after ischemia reperfusion injury in rats.

Authors:  Xiao-Qian Li; Bo Fang; Wen-Fei Tan; Zhi-Lin Wang; Xi-Jia Sun; Zai-Li Zhang; Hong Ma
Journal:  BMC Neurosci       Date:  2016-02-05       Impact factor: 3.288

Review 7.  Effects of GH on the Aging Process in Several Organs: Mechanisms of Action.

Authors:  Jesús Á F Tresguerres; Isabel Fernández-Tresguerres; José Viña; Lisa Rancan; Sergio D Paredes; Beatriz Linillos-Pradillo; Elena Vara
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

Review 8.  Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

Authors:  Carlos G Martínez-Moreno; Denisse Calderón-Vallejo; Steve Harvey; Carlos Arámburo; José Luis Quintanar
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.